SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Business
Gilead Sciences, Inc. Poaches Genentech Exec To Head Cancer Drug Program
December 15, 2014
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Genentech Submits NDA For Skin Cancer Med Cobimetinib
December 15, 2014
 · 
2 min read
Business
Genentech’s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot
December 12, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech Consultants
December 9, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Biotech Bay
Genentech Defends Supply Shift For Top Cancer Drugs
November 25, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Policy
Major Medical Centers Ask Congress To Probe Genentech’s Distribution Changes
November 12, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Genentech, NewLink Genetics Strike $1 Billion+ Cancer Deal
October 20, 2014
 · 
2 min read
Job Trends
Genentech Sales Reps Banned At Ascension Health
October 3, 2014
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech’s New Breast Cancer Drug Greatly Extends Survival Rates
September 29, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Genentech’s Gazyva Extends Leukemia Patients’ Survival
November 7, 2013
 · 
13 min read
FDA
Genentech Grabs Breakthrough Approval for Chronic Leukemia Drug Gazyva
November 1, 2013
 · 
1 min read
BioForest
Genentech Release: Smithsonian Explores Beginnings of Biotechnology
October 24, 2013
 · 
3 min read
FDA
Genentech Gains FDA Approval for New Subcutaneous Formulation of Actemra® for Use in Adult Patients Living With Moderately to Severely Active Rheumatoid Arthritis
October 22, 2013
 · 
8 min read
Business
Argenta Discovery Ltd. Announces Fourth Extension of Drug Discovery Collaboration With Genentech
October 14, 2013
 · 
2 min read
Job Trends
Roche to Spend $880 Million in Biologics Future; Will Inject $285 Million Into Genentech’s Vacaville, Oceanside Sites, Create 250 New Jobs
October 14, 2013
 · 
1 min read
Policy
FDA Files Genentech’s Supplemental Biologics License Application of Xolair®
October 11, 2013
 · 
6 min read
FDA
FDA Approves Genentech’s First Pre-Surgical Breast Cancer Drug
September 30, 2013
 · 
12 min read
Drug Development
Genentech’s Kadcyla Boosts Breast Cancer Suvival Compared to Other Drugs in Phase 3 Study
September 30, 2013
 · 
10 min read
BioCapital
FDA Strengthens Warnings for GlaxoSmithKline’s Arzerra and Genentech’s Rituxan
September 26, 2013
 · 
1 min read
Load More